The biopharma industry is undergoing a transformation. AI-driven drug discovery is producing drug candidates at an unprecedented speed and almost no cost. With the help of AI, even the way we recruit patients and test drugs in a clinical trial is improving. Meanwhile, digital technologies are making possible whole new ways of diagnosing and treating diseases. On April 25, 2024, five experts were invited to share their latest experiences with AI and digital technologies that expedite research and business. These experts included Kim Sun (Professor, Seoul National University), Lee Jeong Seok (Professor, KAIST), Kim Jae Won (CFO and COO, VantAI), Lee Donghoon (CEO, SK Biopharmaceuticals), and Ted Jeong (Managing Partner, Adelphi Ventures).